Invivyd, Inc. — Director's Dealing 2022

Mar 31, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2022-03-28

Reporting Person: MITHRIL II LP (10% Owner, See Remarks)
Reporting Person: Mithril II GP LP (10% Owner, See Remarks)
Reporting Person: Mithril II UGP LLC (10% Owner, See Remarks)
Reporting Person: THIEL PETER (10% Owner, See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11241580	Direct

Footnotes

F1: These shares are held of record by II LP. Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. Ajay Royan ("Royan"), a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. Peter Thiel ("Thiel") and Royan are the members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of UGP II, GP II, Thiel and Royan disclaims beneficial ownership of the shares held by II LP, except to the extent of their respective pecuniary interests therein, if any. Royan is a director of the Issuer and, accordingly, files separate Section 16 reports.